Epidemiology Practice Questions

Q: Which of the following research methods include only people who are initially free of the disease of interest?

Cohort study. **Explanation:** The core principle of a **Cohort Study** is that it begins with a group of individuals (the cohort) who are **initially free of the disease** or outcome of interest. These individuals are classified based on their exposure status (exposed vs. non-exposed) and followed forward in time to observe the development of the disease. Because the study starts before the disease occurs, it is the gold standard for establishing **temporality** (exposure precedes outcome) and calculating **Incidence**. **Why the other options are incorrect:** * **Case series:** These describe a group of patients who **already have the disease**. There is no comparison group, and it is purely descriptive. * **Cross-sectional study:** This is a "snapshot" where exposure and disease are measured **simultaneously**. It includes both diseased and non-diseased individuals at a single point in time, making it impossible to determine if the exposure came before the disease. * **Case-control study:** This study starts with people who **already have the disease** (Cases) and compares them to those who do not (Controls). It looks backward in time to identify risk factors. **High-Yield Clinical Pearls for NEET-PG:** * **Cohort Study:** Best for rare exposures; can calculate Relative Risk (RR) and Attributable Risk (AR). * **Case-Control:** Best for rare diseases; can only calculate Odds Ratio (OR). * **Incidence:** Can only be directly calculated in a Cohort study (since participants start disease-free). * **Mnemonic:** **C**ohort = **C**ause to Effect; **C**ase-Control = **E**ffect to Cause.

Q: Which one of the following is not a special incidence rate?

Standardized mortality rate. ### Explanation To answer this question, it is essential to distinguish between **Incidence** (new cases) and **Mortality** (deaths). **Why the Correct Answer is Right:** **Standardized Mortality Rate (SMR)** is a measure of **mortality**, not morbidity (incidence). It is used in longitudinal studies to compare the observed number of deaths in a study population with the expected number of deaths derived from a standard population. Since it measures death events rather than the occurrence of new disease cases, it cannot be classified as an incidence rate. **Analysis of Incorrect Options:** * **A. Attack Rate:** This is a type of incidence rate used specifically during an epidemic for a narrow population over a short period (e.g., food poisoning). It is calculated as: *(Number of new cases / Population at risk) × 100*. * **B. Secondary Attack Rate (SAR):** This is a special incidence rate that measures the spread of a communicable disease from a primary case to contacts within a closed group (like a household). It reflects the infectivity of an agent. * **C. Hospital Admission Rate:** This is considered a special incidence rate in administrative epidemiology, representing the number of new "events" (admissions) occurring in a population over a specific timeframe. **High-Yield NEET-PG Pearls:** * **Incidence** = New cases / Population at risk. It is the best indicator for the **etiology** of a disease and the **efficacy** of preventive programs. * **Prevalence** = Total cases (Old + New) / Total population. It is best for estimating the **burden** of disease and planning health services. * **SAR Formula:** (Number of cases among contacts / Total number of susceptible contacts) × 100. Note: The denominator excludes those already immune or the primary case. * **SMR Formula:** (Observed deaths / Expected deaths) × 100. An SMR > 100 indicates higher-than-expected mortality.

Q: What does specificity measure?

True negatives. **Explanation:** **Specificity** is a measure of a diagnostic test's ability to correctly identify those **without the disease**. It is defined as the proportion of truly healthy individuals (non-diseased) who are correctly identified as negative by the test. 1. **Why Option A is Correct:** Specificity focuses on the "healthy" column of a 2x2 contingency table. The formula is: **Specificity = [True Negatives (TN) / (True Negatives + False Positives)] × 100.** A highly specific test has very few "False Positives," meaning if the test result is positive, you can be highly confident the patient actually has the disease (Rule: **SpPIn** – Specificity rules **In**). 2. **Why Other Options are Incorrect:** * **Option B (False Positives):** Specificity aims to *minimize* false positives, but it measures the True Negatives. The "False Positive Rate" is actually calculated as (1 - Specificity). * **Option C (True Positives):** This is the definition of **Sensitivity**. Sensitivity measures the ability of a test to correctly identify those *with* the disease (Rule: **SnNOut** – Sensitivity rules **Out**). **NEET-PG High-Yield Pearls:** * **Screening vs. Diagnosis:** Use a highly **Sensitive** test for screening (to catch all cases) and a highly **Specific** test for confirmation (to avoid unnecessary treatment). * **Ideal Test:** An ideal diagnostic test has 100% Sensitivity and 100% Specificity. * **Inverse Relationship:** As you change the "cut-off" point to increase sensitivity, specificity usually decreases, and vice versa. This relationship is visualized using the **ROC (Receiver Operating Characteristic) Curve**.

Q: Which one of the following factors is NOT considered when evaluating a screening program?

Cost of the screening test. ### Explanation The evaluation of a screening program is based on the **Wilson and Jungner criteria**, which outline the requirements for a screening test to be ethically and medically justifiable. **Why "Cost of the screening test" is the correct answer:** While economic feasibility is a consideration in public health policy, the **unit cost of the test itself** is not a primary criterion for evaluating the scientific validity or effectiveness of a screening program. Instead, the focus is on the **cost-effectiveness** of the entire program (including diagnosis and treatment) relative to the benefits gained. A cheap test for a disease with no cure is useless, whereas an expensive test for a treatable condition may be highly valuable. **Analysis of incorrect options:** * **Disease burden (A):** The condition must be an important health problem (high prevalence or high mortality/morbidity) to justify mass screening. * **Physician's knowledge (B):** While often phrased as "the natural history of the disease should be well understood," this includes the medical community's ability to recognize the latent and early symptomatic stages. Without this knowledge, screening cannot be timed effectively. * **Efficacy of available treatments (D):** This is a core ethical requirement. There must be an accepted, effective treatment for patients discovered through screening. Screening without the ability to improve the outcome is considered unethical. **High-Yield Clinical Pearls for NEET-PG:** * **Wilson and Jungner Criteria:** The gold standard for screening evaluation. * **Lead Time Bias:** The apparent increase in survival time due to early diagnosis, even if the actual time of death is not delayed. * **Length Bias:** Screening tends to detect slowly progressing cases (better prognosis) more than rapidly progressing ones. * **Yield:** The amount of previously undiagnosed disease that is detected as a result of the screening program.

Q: Which of the following is NOT a feature of epidemic dropsy?

Convulsions. **Explanation:** Epidemic dropsy is a clinical condition caused by the ingestion of mustard oil contaminated with **Argemone mexicana** (prickly poppy) oil. The toxic alkaloids responsible are **Sanguinarine** and **Dihydrosanguinarine**, which interfere with cellular oxidative phosphorylation. **Why Convulsions is the correct answer:** Epidemic dropsy primarily affects the vascular system, leading to increased capillary permeability and dilatation. While it involves the cardiovascular, gastrointestinal, and ocular systems, it **does not typically involve the Central Nervous System (CNS)**. Therefore, neurological symptoms like convulsions are not a feature of this condition. **Analysis of other options:** * **Glaucoma (Option A):** This is a hallmark feature. Sanguinarine causes dilatation of the uveal tract capillaries, leading to increased aqueous humor production and **open-angle glaucoma**. * **Diarrhoea (Option B):** Gastrointestinal symptoms, including vomiting and diarrhoea, are often the earliest manifestations of the toxicity. * **Heart Failure (Option D):** The toxin causes extensive capillary leakage and peripheral vasodilatation, leading to high-output cardiac failure, which is a common cause of death in these patients. **High-Yield Clinical Pearls for NEET-PG:** * **Causative Agent:** Argemone mexicana (Sanguinarine toxin). * **Test for Detection:** **Nitric Acid Test** (turns orange-red) and **Paper Chromatography** (most sensitive). * **Key Clinical Triad:** Bilateral pitting edema (dropsy), Erythema/Pigmentation of skin, and Cardiac failure. * **Distinguishing Feature:** Unlike nutritional edema, epidemic dropsy is associated with **erythema** and **normal serum albumin** levels. * **Treatment:** No specific antidote; management is symptomatic (bed rest, high protein diet, and antioxidants).

Q: Which of the following is an example of an amplifier host?

Pig in Japanese encephalitis. **Explanation:** In epidemiology, an **amplifier host** is an animal in which an infectious agent (usually a virus) multiplies rapidly to high levels, providing a significant source of infection for vectors (like mosquitoes) to transmit the pathogen to humans. **1. Why Pig in Japanese Encephalitis (JE) is correct:** In the transmission cycle of JE, pigs serve as the primary amplifier hosts. When a *Culex* mosquito bites an infected pig, the virus replicates extensively in the pig's blood (**viremia**) without causing serious illness to the animal. This high viral load ensures that any mosquito biting the pig becomes infected, subsequently spreading the virus to humans (who are "dead-end" hosts). **2. Analysis of Incorrect Options:** * **Dog in Hydatid Disease:** The dog is the **definitive host** because it harbors the adult stage of the parasite *Echinococcus granulosus*. * **Cattle in Mad Cow Disease:** Cattle are the **primary hosts/reservoirs** for the prions causing Bovine Spongiform Encephalopathy (BSE). It is not a vector-borne disease requiring amplification for transmission. * **Rat in Plague:** Rats are **reservoirs** or **maintenance hosts**. While they harbor *Yersinia pestis*, the term "amplifier host" is specifically used in the context of increasing the viral/pathogen titer for vector transmission, whereas rats often die from the plague (epizootic). **Clinical Pearls for NEET-PG:** * **Dead-end Host:** Humans in JE and Rabies (the pathogen cannot be transmitted further). * **Incidental Host:** Humans in JE (we are not part of the natural maintenance cycle). * **JE Vector:** *Culex tritaeniorhynchus* (breeds in rice fields). * **Arbo-viral amplification:** Pigs are to JE what birds are to West Nile Virus.

Q: What is the Pearl index?

Failures per 100 women-years of exposure. The **Pearl Index** is the most common method used in clinical trials and epidemiological studies to express the **efficacy of a contraceptive method**. ### Why Option B is Correct The Pearl Index is defined as the number of unintended pregnancies (failures) per **100 woman-years** of exposure. It standardizes the failure rate over a specific duration of time, allowing for a direct comparison between different contraceptive methods. The formula is: $$\text{Pearl Index} = \frac{\text{Total number of accidental pregnancies} \times 1200}{\text{Total months of exposure (usage)}}$$ *(Note: 1200 represents 100 women multiplied by 12 months in a year).* ### Why Other Options are Incorrect * **Option A, C, and D:** These are mathematically incorrect. The standard denominator for the Pearl Index is always **100 woman-years**. Using 1000, 10, or 1 woman-year would lead to an inaccurate representation of the standardized failure rate used in global medical literature. ### High-Yield Facts for NEET-PG * **Lower is Better:** A lower Pearl Index indicates a more effective contraceptive method (e.g., Implants have a Pearl Index of ~0.05, while the rhythm method can be >20). * **Limitation:** The Pearl Index assumes a constant failure rate over time. However, failure rates usually decrease as users become more experienced with a method. * **Alternative:** The **Life Table Analysis** is considered superior to the Pearl Index because it calculates the failure rate for each month of use, accounting for "drop-outs" or users who switch methods. * **Theoretical vs. Typical Use:** Always distinguish between "Perfect Use" (lowest Pearl Index) and "Typical Use" (higher Pearl Index due to human error).

Question 1

Which of the following research methods include only people who are initially free of the disease of interest?

Accepted Answer

Cohort study

Answer

Case series

Answer

Cross-sectional study

Answer

Case-control study

Question 2

Which one of the following is not a special incidence rate?

Accepted Answer

Standardized mortality rate

Answer

Attack rate

Answer

Secondary attack rate

Answer

Hospital admission rate

Question 3

In a population, changing harmful lifestyles through education to prevent coronary artery disease is referred to as:

Accepted Answer

Primary prevention

Answer

High risk strategy

Answer

Secondary prevention

Answer

Tertiary prevention

Question 4

Which of the following statements is true regarding the Mantoux test?

Accepted Answer

A positive test does not necessarily indicate that the person is suffering from active TB disease.

Answer

The test is read before 48 hours.

Answer

An induration of 6-9 mm indicates the maximum chances of developing TB.

Answer

New cases of TB are more likely to occur in tuberculin-negative individuals than in those who are tuberculin reactors.

Question 5

What does specificity measure?

Accepted Answer

True negatives

Answer

False positives

Answer

True positives

Answer

None of the above

Question 6

Which one of the following factors is NOT considered when evaluating a screening program?

Accepted Answer

Cost of the screening test

Answer

Disease burden

Answer

Physician's knowledge of the disease

Answer

Efficacy of available treatments

Question 7

Which of the following is NOT a feature of epidemic dropsy?

Accepted Answer

Convulsions

Answer

Glaucoma

Answer

Diarrhoea

Answer

Heart failure

Question 8

Which of the following diseases is NOT included in WHO surveillance programs?

Accepted Answer

Viral encephalitis

Answer

Polio

Answer

Malaria

Answer

Relapsing fever

Question 9

Which of the following is an example of an amplifier host?

Accepted Answer

Pig in Japanese encephalitis

Answer

Dog in hydatid disease

Answer

Cattle in mad cow disease

Answer

Rat in plague

Question 10

What is the Pearl index?

Accepted Answer

Failures per 100 women-years of exposure

Answer

Failures per 1000 women-years of exposure

Answer

Failures per 10 women-years of exposure

Answer

Failures per women-years of exposure

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?